PMFA
OSIR

Plante Moran Financial Advisors’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Plante Moran Financial Advisors’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-350
Closed -$2K – 1105
2016
Q4 		$2K Buy
+350
New +$1.79K ﹤0.01% 898

Other funds holding OSIR

HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $359M AUM 23.01% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Plante Moran Financial Advisors's OSIR Position: Q1 2017 in Review

Plante Moran Financial Advisors sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 350 shares — an estimated $2K sold.

Plante Moran Financial Advisors first reported a position in OSIR in Q4 2016 and held it in 1 quarter. The position peaked at $2K in Q4 2016. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.

  • Plante Moran Financial Advisors reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 350 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $2K.
  • Plante Moran Financial Advisors first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2016 and held it in 1 quarter.
  • Plante Moran Financial Advisors's Osiris Therapeutics, Inc. Common Stock position peaked at $2K in Q4 2016.
  • 11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.

Based on Plante Moran Financial Advisors's 13F filing for Q1 2017, filed 1 May 2017.